Personal information

Websites & social links

Calamai lab

Other IDs

Scopus Author ID: 7003913535

Keywords

LS3_16 - Functional imaging of cells and tissues, LS5_11 - Neurological and neurodegenerative disorders, LS1_1 - Macromolecular complexes including interactions involving nucleic acids, proteins, peptides, lipids and carbohydrates

Activities

Collapse all

Employment (3)

Consiglio Nazionale delle Ricerche: Roma, Lazio, IT

2012 to present | Researcher (Istituto Nazionale di Ottica)
Employment
Source: Self-asserted source
Martino Calamai

Laboratorio Spettroscopie Non Lineari LENS: Sesto Fiorentino, Firenze, IT

2009 to 2012 | postdoc
Employment
Source: Self-asserted source
Martino Calamai

Ecole Normale Supérieure: Paris, FR

2006 to 2008 | postdoc ( Département de Biologie)
Employment
Source: Self-asserted source
Martino Calamai

Education and qualifications (2)

University of Cambridge: Cambridge, Cambridgeshire, GB

2002 to 2006 | PhD in Chemistry (Department of Chemistry)
Education
Source: Self-asserted source
Martino Calamai

Università degli Studi di Firenze: Firenze, Toscana, IT

1996 to 2001 | Graduation degree in Biology
Education
Source: Self-asserted source
Martino Calamai

Funding (2)

Nose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systems

2021-01-01 to 2024-12-31 | Grant
European Commission (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.9385350
GRANT_NUMBER: 956977
Source: Self-asserted source
Martino Calamai via DimensionsWizard

Nose to Brain Delivery of NG-101 via the Olfactory Region for the Regenerative Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device

2017-01-01 to 2020-12-31 | Grant
European Commission (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.6493653
GRANT_NUMBER: 721098
Source: Self-asserted source
Martino Calamai via DimensionsWizard

Peer review (1 review for 1 publication/grant)

Review activity for Molecular genetics and genomics. (1)
How many people are using ORCID?